These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 23467223)

  • 1. Biotech comes to its 'antisenses' after hard-won drug approval.
    Jiang K
    Nat Med; 2013 Mar; 19(3):252. PubMed ID: 23467223
    [No Abstract]   [Full Text] [Related]  

  • 2. Antisense battles small molecule for slice of rare lipid disorder market.
    Sinha G
    Nat Biotechnol; 2013 Mar; 31(3):179-80. PubMed ID: 23471047
    [No Abstract]   [Full Text] [Related]  

  • 3. Lack of clinical pharmacodynamic and pharmacokinetic drug-drug interactions between warfarin and the antisense oligonucleotide mipomersen.
    Li Z; Hard ML; Grundy JS; Singh T; von Moltke LL; Boltje I
    J Cardiovasc Pharmacol; 2014 Aug; 64(2):164-71. PubMed ID: 24691275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ISIS 2302. INXC ICAM1, Oligo-TCS.
    Drugs R D; 1999 Jan; 1(1):85-6. PubMed ID: 10565996
    [No Abstract]   [Full Text] [Related]  

  • 5. Mipomersen and other therapies for the treatment of severe familial hypercholesterolemia.
    Bell DA; Hooper AJ; Watts GF; Burnett JR
    Vasc Health Risk Manag; 2012; 8():651-9. PubMed ID: 23226021
    [TBL] [Abstract][Full Text] [Related]  

  • 6. ISIS 2302. Oligo-TCS.
    Drugs R D; 1999 Mar; 1(3):265-7. PubMed ID: 10566042
    [No Abstract]   [Full Text] [Related]  

  • 7. Apolipoprotein B antisense inhibition--update on mipomersen.
    Gebhard C; Huard G; Kritikou EA; Tardif JC
    Curr Pharm Des; 2013; 19(17):3132-42. PubMed ID: 23317401
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mipomersen sodium: first global approval.
    Hair P; Cameron F; McKeage K
    Drugs; 2013 Apr; 73(5):487-93. PubMed ID: 23564617
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Technology evaluation: alicaforsen (Isis).
    Gewirtz AT; Sitaraman SV
    Curr Opin Mol Ther; 2005 Jun; 7(3):273-81. PubMed ID: 15977426
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Two new drugs for homozygous familial hyperchelesterolemia.
    Med Lett Drugs Ther; 2013 Apr; 55(1413):25-7. PubMed ID: 23545581
    [No Abstract]   [Full Text] [Related]  

  • 11. Novel strategies to control lipid metabolism: can the antisense drug mipomersen fulfill the unmet need?
    Merk D; Schubert-Zsilavecz M
    Future Med Chem; 2012 Sep; 4(14):1773-5. PubMed ID: 23043473
    [No Abstract]   [Full Text] [Related]  

  • 12. Oligonucleotides as inhibitors of human immunodeficiency virus.
    Field AK
    Curr Opin Mol Ther; 1999 Jun; 1(3):323-31. PubMed ID: 11713797
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense oligonucleotides in lung cancer.
    Pujol JL; Jacot W
    Suppl Tumori; 2002; 1(4):S50-1. PubMed ID: 12415820
    [No Abstract]   [Full Text] [Related]  

  • 14. Biodistribution, stability, and antiviral efficacy of liposome-entrapped phosphorothioate antisense oligodeoxynucleotides in ducks for the treatment of chronic duck hepatitis B virus infection.
    Soni PN; Brown D; Saffie R; Savage K; Moore D; Gregoriadis G; Dusheiko GM
    Hepatology; 1998 Nov; 28(5):1402-10. PubMed ID: 9794928
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gene therapy briefs.
    Philippidis A
    Hum Gene Ther; 2012 Dec; 23(12):1221-3. PubMed ID: 23234557
    [No Abstract]   [Full Text] [Related]  

  • 16. Two new drugs for homozygous familial hypercholesterolemia: managing benefits and risks in a rare disorder.
    Smith RJ; Hiatt WR
    JAMA Intern Med; 2013 Sep; 173(16):1491-2. PubMed ID: 23649296
    [No Abstract]   [Full Text] [Related]  

  • 17. Trial watch: Antisense agent reduces LDL-cholesterol levels in high-risk patients.
    Nat Rev Drug Discov; 2010 Jan; 9(1):10. PubMed ID: 20043021
    [No Abstract]   [Full Text] [Related]  

  • 18. Challenges and opportunities for local and systemic delivery of siRNA and antisense oligonucleotides.
    Sepp-Lorenzino L; Ruddy M
    Clin Pharmacol Ther; 2008 Nov; 84(5):628-32. PubMed ID: 18800034
    [No Abstract]   [Full Text] [Related]  

  • 19. Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials.
    Santos RD; Raal FJ; Catapano AL; Witztum JL; Steinhagen-Thiessen E; Tsimikas S
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):689-99. PubMed ID: 25614280
    [TBL] [Abstract][Full Text] [Related]  

  • 20. For patients who inherit homozygous familial hypercholesterolemia, 2 new treatments available.
    Morrow T
    Manag Care; 2013 Mar; 22(3):47-8. PubMed ID: 23610808
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.